Shimadzu and Kobe University Jointly Identify Key Proteins in Kidney Cancer.Tokyo, Japan, June 15, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Shimadzu Corporation has discovered several types of protein that may play a role in the diagnosis and treatment of kidney cancer Kidney Cancer Definition Kidney cancer is a disease in which the cells in certain tissues of the kidney start to grow uncontrollably and form tumors. in collaboration with Kobe University. Using Shimadzu's proprietary NBS (National Bureau of Standards) See NIST. NBS - National Bureau of Standards: part of the US Department of Commerce, now NIST. (2-nitrobenzensulfenyl) reagents, the two partners have discovered 106 different types of protein in cancer cells and 28 different types of protein in normal cells, and identified the structures of these proteins. The partners plan to proceed with research on the newly identified proteins, in particular those that increase in cancer cells, aiming to elucidate a mechanism and develop a method to treat kidney cancer. Details of the research will be presented at the 20th IUBMB IUBMB International Union of Biochemistry and Molecular Biology International Congress of Biochemistry and Molecular Biology to be held this month and the 23rd Annual Meeting of the Japan Society for Therapeutic Drug Monitoring therapeutic drug monitoring Clinical pharmacology The regular measurement of serum levels of drugs requiring close 'titration' of doses in order to ensure that there are sufficient levels in the blood to be therapeutically effective, while avoiding potentially to be held in July. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion